Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
perindopril erbumine, Quantity: 4 mg; indapamide hemihydrate, Quantity: 1.25 mg
Servier Laboratories (Aust) Pty Ltd
Tablet, uncoated
Excipient Ingredients: magnesium stearate; microcrystalline cellulose; hydrophobic colloidal silica anhydrous; lactose monohydrate
Oral
30 tablets
(S4) Prescription Only Medicine
Treatment of hypertension. Treatment should not be initiated with this combination.
Visual Identification: White, 8 mm x 4 mm rod-shaped tablets (unscored).; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2003-05-27
IDAPREX® COMBI 4/1.25 1 IDAPREX ® COMBI 4/1.25 _perindopril (pronounced per-in-do-pril) and indapamide (pronounced in-dap-a-mide) _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about IDAPREX COMBI 4/1.25. It does not contain all the available information about this medicine. Reading this leaflet does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking IDAPREX COMBI 4/1.25 against the expected benefits for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT IDAPREX COMBI 4/1.25 IS The name of your medicine is IDAPREX COMBI 4/1.25. The medicine contains the active ingredients perindopril erbumine and indapamide hemihydrate. Perindopril belongs to a group of medicines called angiotensin converting enzyme (ACE) inhibitors. Indapamide belongs to a group of medicines called diuretics (a type of "water" tablet). WHAT IDAPREX COMBI 4/1.25 IS USED FOR YOU HAVE BEEN PRESCRIBED IDAPREX COMBI 4/1.25 FOR HIGH BLOOD PRESSURE. IDAPREX COMBI 4/1.25 is available only with a doctor's prescription. There is no evidence that IDAPREX COMBI 4/1.25 is addictive. _WHY IDAPREX COMBI 4/1.25 _ _IS USED FOR HIGH BLOOD _ _PRESSURE _ Everyone has blood pressure. This pressure helps to circulate blood all around the body. Your blood pressure may be different at different times of the day, depending on how busy or stressed you are. You have high blood pressure (also known as hypertension) when your blood pressure stays higher than is needed, even when you are calm and relaxed. If high blood pressure is not treated it can lead to serious health problems. You may feel fine and have no symptoms, but eventually it can cause stroke, heart disease and kidney failure. IDAPREX COMBI 4/1.25 helps to lower your blood pressure. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IDAPREX COMBI 4/1.25 H Baca dokumen lengkap
AUSTRALIAN PRODUCT INFORMATION IDAPREX COMBI 4/1.25 (PERINDOPRIL ERBUMINE / INDAPAMIDE HEMIHYDRATE) Version: 17 1/35 AUSTRALIAN PRODUCT INFORMATION - IDAPREX COMBI 4/1.25 (PERINDOPRIL ERBUMINE / INDAPAMIDE HEMIHYDRATE) UNCOATED TABLETS 1 NAME OF THE MEDICINE Perindopril erbumine / indapamide hemihydrate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The active components of IDAPREX COMBI 4/1.25 are perindopril erbumine and indapamide hemihydrate. Each IDAPREX COMBI 4/1.25 tablet contains 4 mg of perindopril erbumine and 1.25 mg of indapamide hemihydrate. Excipient with known effect: contains sugars as lactose. For the full list of excipients, see_ section 6.1 - List of _ _excipients_. 3 PHARMACEUTICAL FORM IDAPREX COMBI 4/1.25 is a white rod-shaped uncoated tablet. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Treatment of hypertension. Treatment should not be initiated with this combination. 4.2 D OSE AND METHOD OF ADMINISTRATION One IDAPREX COMBI 4/1.25 tablet per day as a single dose, preferably to be taken in the morning. ELDERLY PATIENTS Renal insufficiency is commonly observed in elderly people. Care should therefore be taken when prescribing perindopril-containing medicines to elderly hypertensive patients. The initial daily dose in the elderly should always be at a low dose or with one component only, and patients should be monitored closely during the initial stages of treatment. Particular care should be taken in elderly patients with congestive heart failure who have renal and/or hepatic insufficiency (see_ section 4.4 - Special warnings and precautions for use_). PATIENTS WITH RENAL INSUFFICIENCY In cases of severe renal insufficiency (creatinine clearance below 30 mL/min), the treatment is contraindicated. In patients with moderate renal insufficiency (creatinine clearance 30-60 mL/min), the maximum dose should be a low dose or with one component only. In patients with a creatinine clearance greater than 60 mL/min, no dose adaptation is required. Normal medical practice includes periodic control fo Baca dokumen lengkap